National Health Investors, Inc. (NYSE:NHI) Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in shares of National Health Investors, Inc. (NYSE:NHI) by 18.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 7,193 shares of the real estate investment trust’s stock after acquiring an additional 1,142 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in National Health Investors were worth $402,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in National Health Investors by 5.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,944 shares of the real estate investment trust’s stock worth $1,127,000 after buying an additional 1,190 shares during the last quarter. International Assets Investment Management LLC grew its stake in shares of National Health Investors by 3,690.7% during the 4th quarter. International Assets Investment Management LLC now owns 28,430 shares of the real estate investment trust’s stock valued at $1,588,000 after buying an additional 27,680 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its stake in National Health Investors by 4.6% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 189,221 shares of the real estate investment trust’s stock worth $10,568,000 after acquiring an additional 8,316 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its position in National Health Investors by 14.4% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 30,971 shares of the real estate investment trust’s stock worth $1,730,000 after purchasing an additional 3,907 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. grew its stake in National Health Investors by 36.2% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 14,743 shares of the real estate investment trust’s stock worth $757,000 after buying an additional 3,916 shares during the period. Hedge funds and other institutional investors own 62.51% of the company’s stock.

National Health Investors Price Performance

NHI stock opened at $62.61 on Friday. The stock’s 50 day moving average is $59.56 and its two-hundred day moving average is $55.61. National Health Investors, Inc. has a 52-week low of $47.54 and a 52-week high of $63.19. The company has a market capitalization of $2.72 billion, a PE ratio of 20.00 and a beta of 0.95. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Investors of record on Thursday, March 28th will be paid a $0.90 dividend. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.75%. National Health Investors’s dividend payout ratio (DPR) is presently 115.02%.

Insider Activity at National Health Investors

In related news, Director Charlotte A. Swafford acquired 10,000 shares of the firm’s stock in a transaction on Tuesday, February 27th. The stock was bought at an average cost of $58.69 per share, with a total value of $586,900.00. Following the acquisition, the director now directly owns 110,185 shares in the company, valued at $6,466,757.65. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 7.26% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on NHI shares. Truist Financial raised their target price on shares of National Health Investors from $55.00 to $58.00 and gave the company a “hold” rating in a research note on Thursday, April 4th. BMO Capital Markets upgraded National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price objective on the stock in a research note on Tuesday, March 12th. Wedbush upped their target price on National Health Investors from $64.00 to $66.00 and gave the stock an “outperform” rating in a research report on Monday, March 18th. Deutsche Bank Aktiengesellschaft initiated coverage on National Health Investors in a report on Tuesday, January 30th. They set a “buy” rating and a $69.00 target price on the stock. Finally, Wells Fargo & Company upgraded National Health Investors from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $55.00 to $63.00 in a report on Monday, February 26th. Five research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $60.50.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.